Track topics on Twitter Track topics that are important to you
Customers Choose from a Wider Spectrum of Flavor Profiles BOSTON, Aug. 12, 2019 /PRNewswire/ — Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalactone from natural substrates using its proprietary technology. Found in many ripe fruits and particularly peaches, γ-Decalactone […]
The post Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones appeared first on SynBioBeta.NEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...